In the November 27,2010 issue of the World Journal of Hepatology (WJH),three case reports were published which involved patients who had consumed various dietary supplements and conventional foods generally marketed a...In the November 27,2010 issue of the World Journal of Hepatology (WJH),three case reports were published which involved patients who had consumed various dietary supplements and conventional foods generally marketed as weight loss products.The reference to Herbalife products as contaminated and generally com-parable to all dietary supplements or weight loss prod-ucts is not scientifically supported.The authors provided an insufficient amount of information regarding patient histories,concomitant medications and other com-pounds,dechallenge results,and product specifications and usage.This information is necessary to fully assess the association of Herbalife products in the WJH case reports.Therefore,the article does not objectively sup-port a causal relationship between the reported cases of liver injury and Herbalife products or ingredients.展开更多
The authors of the subject article by Senadhi et al have misrepresented the safety and regulatory status of Herbalife's products. While we are very concerned with the unwarranted and unfavorable publicity that the...The authors of the subject article by Senadhi et al have misrepresented the safety and regulatory status of Herbalife's products. While we are very concerned with the unwarranted and unfavorable publicity that the inaccuracies listed could generate for Herbalife, we would welcome any inquiries that these authors may have to better clarify our commitment to the safety and quality of our products as has been demonstrated in part by our ability to establish positive relationships with regulatory authorities worldwide through continued cooperation and compliance. This letter clarifies the misinformation presented about Herbalife in the subject article.展开更多
文摘In the November 27,2010 issue of the World Journal of Hepatology (WJH),three case reports were published which involved patients who had consumed various dietary supplements and conventional foods generally marketed as weight loss products.The reference to Herbalife products as contaminated and generally com-parable to all dietary supplements or weight loss prod-ucts is not scientifically supported.The authors provided an insufficient amount of information regarding patient histories,concomitant medications and other com-pounds,dechallenge results,and product specifications and usage.This information is necessary to fully assess the association of Herbalife products in the WJH case reports.Therefore,the article does not objectively sup-port a causal relationship between the reported cases of liver injury and Herbalife products or ingredients.
文摘The authors of the subject article by Senadhi et al have misrepresented the safety and regulatory status of Herbalife's products. While we are very concerned with the unwarranted and unfavorable publicity that the inaccuracies listed could generate for Herbalife, we would welcome any inquiries that these authors may have to better clarify our commitment to the safety and quality of our products as has been demonstrated in part by our ability to establish positive relationships with regulatory authorities worldwide through continued cooperation and compliance. This letter clarifies the misinformation presented about Herbalife in the subject article.
